XML 104 R86.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity and Share-Based Compensation - Stock Options Outstanding and Exercisable (Details) - Amended and Restated 2010 Incentive Plan - Stock Options - USD ($)
$ / shares in Units, shares in Thousands
1 Months Ended 12 Months Ended
Feb. 28, 2021
Dec. 31, 2022
Number of Shares    
Stock Options, Outstanding as of December 31, 2021   60
Stock Options, Granted 40 40
Stock Options, Exercised   (16)
Stock Options, Outstanding as of December 31, 2022   84
Stock Options, Exercisable as of December 31, 2022   44
Stock Options, Expected to vest as of December 31, 2022   40
Weighted Average Exercise Price    
Weighted Average Exercise Price, Outstanding as of December 31, 2021   $ 14.13
Weighted Average Exercise Price, Granted   135.86
Weighted Average Exercise Price, Exercised   14.13
Weighted Average Exercise Price, Outstanding as of December 31, 2022   72.18
Weighted Average Exercise Price, Exercisable as of December 31, 2022   14.13
Weighted Average Exercise Price, Expected to vest as of December 31, 2022   $ 135.86
Weighted Average Remaining Contractual Term (years)    
Weighted Average Remaining Contractual Term, Outstanding as of December 31, 2022   4 years 7 months 17 days
Weighted Average Remaining Contractual Term, Exercisable as of December 31, 2022   3 years 3 months
Weighted Average Remaining Contractual Term, Expected to vest as of December 31, 2022   6 years 1 month 28 days
Aggregate Intrinsic Value    
Aggregate Intrinsic Value, Outstanding as of December 31, 2022   $ 5,346,130
Aggregate Intrinsic Value, Expected to vest as of December 31, 2022   $ 5,345,730